TapewireFind a company

person · Reporting owner

Griggs James M

Disclosed activity across 1 company

Tapewire entity
64416
SEC CIK
0001753380

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
EQUIFAX INCEFX · Entity 3235SVP & Corp ControllerFebruary 25, 2026February 27, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

EQUIFAX INC

Report date February 25, 2026 · Filed February 27, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect6,326 Reported balance After 2026-02-25 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-02-25 · Grant · Acquired 1,641 · Balance 6,326

F1: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 25, 2029.

F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Filing footnotes · ownership attribution and instrument terms

F1: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 25, 2029.

F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
February 25, 2026 Filed Feb 27, 2026 21:14 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 1,641 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-002760 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,326

F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 25, 2029.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 10, 2026 Filed Feb 12, 2026 21:08 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 327 $202.71 $66,286.17
Disclosure

SEC source: 0001225208-26-001774 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,685

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 11, 2025 Filed Feb 13, 2025 21:13 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 225 $253.00 $56,925.00
Disclosure

SEC source: 0001225208-25-001649 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,996

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 21:15 UTC EQUIFAX INC EFX · Entity 3235 GrantStock Option/Right to Buy · Derivative 1,970 $0.00 Strike: $252.90 $0.00
Disclosure

SEC source: 0001225208-25-001582 · doc4.xml · derivative · entry 2

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,970

Underlying: Common Stock · 1,970 shares

Expires 2035-02-10

F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2026.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 21:15 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 613 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-001582 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,221

F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2028.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:13 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 233 $228.29 $53,191.85
Disclosure

SEC source: 0001225208-24-006562 · doc4.xml · nonDerivative · entry 3

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,601

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024.

F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $227.82 to $228.66, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:13 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 131 $229.09 $30,010.21
Disclosure

SEC source: 0001225208-24-006562 · doc4.xml · nonDerivative · entry 2

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,834

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024.

F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $228.85 to $229.525, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:13 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 36 $230.03 $8,281.15
Disclosure

SEC source: 0001225208-24-006562 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,965

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $230.03 to $230.10, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
May 24, 2024 Filed May 29, 2024 20:39 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionStock Option/Right to Buy · Derivative 2,400 $0.00 Strike: $97.19 $0.00
Disclosure

SEC source: 0001225208-24-006426 · doc4.xml · derivative · entry 9

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,305

Underlying: Common Stock · 2,400 shares

Expires 2028-10-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024.

F9 · derivative.exercise_date: The option vested in three equal annual increments beginning 10/26/2019.

Read SEC document
May 24, 2024 Filed May 29, 2024 20:39 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionStock Option/Right to Buy · Derivative 10 $0.00 Strike: $105.99 $0.00
Disclosure

SEC source: 0001225208-24-006426 · doc4.xml · derivative · entry 8

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10 shares

Expires 2027-09-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024.

F8 · derivative.exercise_date: The option vested in three equal annual increments beginning 9/29/2018.

Read SEC document
May 24, 2024 Filed May 29, 2024 20:39 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 1,468 $239.16 $351,091.87
Disclosure

SEC source: 0001225208-24-006426 · doc4.xml · nonDerivative · entry 7

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,001

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024.

F7 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $238.64 to $239.48, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
May 24, 2024 Filed May 29, 2024 20:39 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 320 $239.87 $76,757.31
Disclosure

SEC source: 0001225208-24-006426 · doc4.xml · nonDerivative · entry 6

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,469

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024.

F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $239.675 to $240.25, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
May 24, 2024 Filed May 29, 2024 20:39 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 289 $236.88 $68,459.01
Disclosure

SEC source: 0001225208-24-006426 · doc4.xml · nonDerivative · entry 5

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,789

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024.

F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $236.615 to $237.41, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
May 24, 2024 Filed May 29, 2024 20:39 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 228 $235.51 $53,695.98
Disclosure

SEC source: 0001225208-24-006426 · doc4.xml · nonDerivative · entry 4

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,078

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024.

F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $235.045 to $235.815, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
May 24, 2024 Filed May 29, 2024 20:39 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 105 $238.20 $25,011.01
Disclosure

SEC source: 0001225208-24-006426 · doc4.xml · nonDerivative · entry 3

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,306

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $237.645 to $238.40, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
May 24, 2024 Filed May 29, 2024 20:39 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionCommon Stock 10 $105.99 $1,059.90
Disclosure

SEC source: 0001225208-24-006426 · doc4.xml · nonDerivative · entry 2

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,411

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
May 24, 2024 Filed May 29, 2024 20:39 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionCommon Stock 2,400 $97.19 $233,256.00
Disclosure

SEC source: 0001225208-24-006426 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,401

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:49 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 324 $255.78 $82,872.72
Disclosure

SEC source: 0001225208-24-002068 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,999

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 09, 2024 Filed Feb 13, 2024 21:10 UTC EQUIFAX INC EFX · Entity 3235 GrantStock Option/Right to Buy · Derivative 1,936 $0.00 Strike: $249.18 $0.00
Disclosure

SEC source: 0001225208-24-001931 · doc4.xml · derivative · entry 2

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,936

Underlying: Common Stock · 1,936 shares

Expires 2034-02-09

F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 9, 2025.

Read SEC document
February 09, 2024 Filed Feb 13, 2024 21:10 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 602 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-001931 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,323

F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 9, 2027.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
May 31, 2023 Filed Jun 1, 2023 20:16 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 250 $210.00 $52,500.00
Disclosure

SEC source: 0001225208-23-006423 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,709

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/24/2023.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
May 26, 2023 Filed May 30, 2023 20:15 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 82 $211.09 $17,309.26
Disclosure

SEC source: 0001225208-23-006263 · doc4.xml · nonDerivative · entry 4

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,959

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/24/2023.

F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $210.80 to $211.36, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
May 26, 2023 Filed May 30, 2023 20:15 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 68 $210.19 $14,292.85
Disclosure

SEC source: 0001225208-23-006263 · doc4.xml · nonDerivative · entry 3

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,041

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/24/2023.

F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $209.60 to $210.49, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
May 26, 2023 Filed May 30, 2023 20:15 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 66 $208.32 $13,749.14
Disclosure

SEC source: 0001225208-23-006263 · doc4.xml · nonDerivative · entry 2

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,109

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/24/2023.

F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $207.84 to $208.78, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
May 26, 2023 Filed May 30, 2023 20:15 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 34 $206.98 $7,037.40
Disclosure

SEC source: 0001225208-23-006263 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,175

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/24/2023.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $206.40 to $207.30, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 21:07 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 331 $203.81 $67,461.11
Disclosure

SEC source: 0001225208-23-002656 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,206

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:14 UTC EQUIFAX INC EFX · Entity 3235 GrantStock Option/Right to Buy · Derivative 2,281 $0.00 Strike: $206.16 $0.00
Disclosure

SEC source: 0001225208-23-001895 · doc4.xml · derivative · entry 2

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,281

Underlying: Common Stock · 2,281 shares

Expires 2033-02-10

F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2024.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:14 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 716 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-001895 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,537

F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2026.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 14, 2022 Filed Nov 15, 2022 21:11 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 300 $200.00 $60,000.00
Disclosure

SEC source: 0001225208-22-011681 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,820

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/22/2022.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 20:08 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 56 $168.99 $9,463.44
Disclosure

SEC source: 0001225208-22-011321 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,120

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:11 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 505 $219.04 $110,615.20
Disclosure

SEC source: 0001225208-22-004062 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,160

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 22:34 UTC EQUIFAX INC EFX · Entity 3235 GrantStock Option/Right to Buy · Derivative 2,221 $0.00 Strike: $225.00 $0.00
Disclosure

SEC source: 0001225208-22-002196 · doc4.xml · derivative · entry 2

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,221

Underlying: Common Stock · 2,221 shares

Expires 2032-02-11

F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/11/2023.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 22:34 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 556 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002196 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,665

F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/11/2025.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
October 26, 2021 Filed Oct 27, 2021 20:23 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 288 $270.97 $78,039.36
Disclosure

SEC source: 0001225208-21-013309 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,112

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 20:12 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionStock Option/Right to Buy · Derivative 1,887 $0.00 Strike: $105.99 $0.00
Disclosure

SEC source: 0001225208-21-011699 · doc4.xml · derivative · entry 5

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,887 shares

Expires 2027-09-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 5/24/2021.

F5 · derivative.exercise_date: The option vested in three equal annual increments beginning 9/29/2018.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 20:12 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 1,027 $257.25 $264,196.98
Disclosure

SEC source: 0001225208-21-011699 · doc4.xml · nonDerivative · entry 4

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,394

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 5/24/2021.

F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $256.805 to $257.68, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 20:12 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 845 $256.20 $216,485.28
Disclosure

SEC source: 0001225208-21-011699 · doc4.xml · nonDerivative · entry 3

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,421

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 5/24/2021.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $255.71 to $256.62, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 20:12 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 5 $258.50 $1,292.50
Disclosure

SEC source: 0001225208-21-011699 · doc4.xml · nonDerivative · entry 2

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,266

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 5/24/2021.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 20:12 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionCommon Stock 1,887 $105.99 $200,003.13
Disclosure

SEC source: 0001225208-21-011699 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,271

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 5/24/2021.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 12, 2021 Filed Feb 17, 2021 22:22 UTC EQUIFAX INC EFX · Entity 3235 GrantStock Option/Right to Buy · Derivative 3,105 $0.00 Strike: $177.19 $0.00
Disclosure

SEC source: 0001225208-21-002794 · doc4.xml · derivative · entry 2

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,105

Underlying: Common Stock · 3,105 shares

Expires 2031-02-12

F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/12/2022.

Read SEC document
February 12, 2021 Filed Feb 17, 2021 22:22 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 776 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-002794 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,369

F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/12/2024.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
September 29, 2020 Filed Oct 1, 2020 20:14 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 149 $157.84 $23,518.16
Disclosure

SEC source: 0001225208-20-011984 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,584

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 21, 2020 Filed Feb 25, 2020 21:56 UTC EQUIFAX INC EFX · Entity 3235 GrantStock Option/Right to Buy · Derivative 3,075 $0.00 Strike: $159.53 $0.00
Disclosure

SEC source: 0001225208-20-003464 · doc4.xml · derivative · entry 2

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,075

Underlying: Common Stock · 3,075 shares

Expires 2030-02-21

F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/21/2021.

Read SEC document
February 21, 2020 Filed Feb 25, 2020 21:56 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 767 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-003464 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,703

F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/21/2023.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 01, 2019 Filed Nov 26, 2019 21:03 UTC EQUIFAX INC EFX · Entity 3235 GrantStock Option/Right to Buy · Derivative 722 $0.00 Strike: $138.70 $0.00
Disclosure

SEC source: 0001225208-19-014917 · doc4.xml · derivative · entry 2

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 722

Underlying: Common Stock · 722 shares

Expires 2029-11-01

F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 11/1/2020.

Read SEC document
November 01, 2019 Filed Nov 26, 2019 21:03 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 180 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-014917 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,927

F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 11/1/2022.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
September 30, 2019 Filed Oct 2, 2019 17:50 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 296 $140.67 $41,638.32
Disclosure

SEC source: 0001225208-19-012987 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,747

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 21:52 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 1,630 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-004611 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,018

F1 · security: Equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 3/1/2022.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
October 26, 2018 Filed Oct 30, 2018 20:13 UTC EQUIFAX INC EFX · Entity 3235 GrantStock Option/Right to Buy · Derivative 3,705 $0.00 Strike: $97.19 $0.00
Disclosure

SEC source: 0001225208-18-014958 · doc4.xml · derivative · entry 2

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,705

Underlying: Common Stock · 3,705 shares

Expires 2028-10-26

F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 10/26/2019.

Read SEC document
October 26, 2018 Filed Oct 30, 2018 20:13 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 926 $0.00 $0.00
Disclosure

SEC source: 0001225208-18-014958 · doc4.xml · nonDerivative · entry 1

Griggs James M · CIK 0001753380 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,387

F1 · security: Annual equity grant pursuant to the Company'g long-term incentive plan. The award of restricted stock units vests 100% on 10/26/21.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.